INSTITUT FÜR MEDIZINISCHE MIKROBIOLOGIE UND KRANKENHAUSHYGIENE

Forschung/Publikationen

Probst-Kepper M, Geginat G.
Neue Antibiotika für die Therapie von multiresistenten gramnegativen Bakterien.
Anästhesiol Intensivmed Notfallmed Schmerzther. 2018. 53:529-542.

Mertens A, Barche D, Scheinpflug L, Scholz FG, Vielhaber S, Scherlach C, Tröger U, Geginat G, Färber J, Arens C. 
Rhinocerebral Mucormycosis.
Laryngorhinootologie. 2018 May 16. doi: 10.1055/a-0619-5143. [Epub ahead of print] German. PMID: 29768642

Geginat G, Probst-Kepper, M. 
Neue Antibiotika gegen multiresistente Bakterien.
Der Mikrobiologe. 2017. 27 (4), 177-183

Sitte-Zöllner A, Walcher F, Geginat G, Piatek S. Letter to the Editor: A.Probst, N. Reimers, A. Hecht, R. Langenhan:
Geriatrische proximale Femurfraktur und Harnwegsinfekt – Überlegungen zur perioperativen Infektionsprophylaxe.
Z Orthop Unfall. 2017 Jun;155(3):344-345. doi: 10.1055/s-0043-103015. Epub 2017 Jul, 6. German. PubMed PMID: 28683498.

Färber J, Illiger S, Berger F, Gärtner B, von Müller L, Lohmann CH, Bauer K, Grabau C, Zibolka S, Schlüter D, Geginat G.
Management of a cluster of Clostridium difficile infections among patients with osteoarticular infections.
Antimicrob Resist Infect Control. 2017 Feb 15;6:22. doi: 10.1186/s13756-017-0181-4. eCollection 2017. PubMed PMID: 28239451; PubMed Central PMCID: PMC5312516.

Tammer I, Geginat G, Lange S, Kropf S, Lodes U, Schlüter D, Lippert H, Meyer F.
[Antibiotic Consumption and the Development of Antibiotic Resistance in Surgical Units].
Zentralbl Chir. 2016 Feb;141(1):53-61. doi:10.1055/s-0033-1351087. Epub 2014 Apr 28. German. PubMed PMID: 24777619.

Walch-Rückheim B, Kiefer R, Geginat G, Schmitt MJ, Breinig F.
Coexpression of human perforin improves yeast-mediated delivery of DNA and mRNA to mammalian antigen-presenting cells.
Gene Ther. 2016 Jan;23(1):103-7. doi:10.1038/gt.2015.77. Epub 2015 Aug 20. PubMed PMID: 26289665.

Krause J, Geginat G, Tammer I.
Prostaglandin E2 from Candida albicans Stimulates the Growth of Staphylococcus aureus in Mixed Biofilms.
PLoS One. 2015 Aug 11;10(8):e0135404. doi: 10.1371/journal.pone.0135404. eCollection 2015. PubMed PMID: 26262843; PubMed Central PMCID: PMC4532413.

Stokkou S, Geginat G, Schlüter D, Tammer I.
Direct disk diffusion test using European Clinical Antimicrobial Susceptibility Testing breakpoints provides reliable results compared with the standard method.
Eur J Microbiol Immunol (Bp). 2015 Mar;5(1):103-11. doi: 10.1556/EUJMI-D-15-00005. Epub 2015 Mar 26. PubMed; PMID: 25883798; PubMed Central PMCID: PMC4397852.

Stokkou S, Tammer I, Zibolka S, Grabau C, Geginat G.
Impact of minimal inhibitory concentration breakpoints on local cumulative bacterial susceptibility data and antibiotic consumption.
BMC Res Notes. 2014 Sep 3;7:603. doi: 10.1186/1756-0500-7-603. PubMed PMID: 25185565; PubMed Central PMCID: PMC4161835.

Herter I, Geginat G, Hof H, Kupfahl C.
Modulation of innate and antigen-specific immune functions directed against Listeria monocytogenes by fungal toxins in vitro.
Mycotoxin Res. 2014 May;30(2):79-87. doi:10.1007/s12550-014-0191-5. Epub 2014 Feb 14. PubMed PMID: 24526341.

Tammer I, Reuner J, Hartig R, Geginat G.
Induction of Candida albicans biofilm formation on silver-coated vascular grafts.
J Antimicrob Chemother. 2014 May;69(5):1282-5. doi: 10.1093/jac/dkt521. Epub 2014 Jan 20. PubMed PMID: 24448486.

Schalk E, Geginat G, Schulz C, Schlüter D, Fischer T.
The incidence of norovirus infections in cancer patients shows less seasonal variability compared to patients with other diseases.
Ann Hematol. 2014 May;93(5):889-90. doi: 10.1007/s00277-013-1885-z. Epub 2013 Aug 31. PubMed PMID: 23995577.

Letzte Änderung: 17.07.2019 - Ansprechpartner:

Sie können eine Nachricht versenden an: Webmaster
Sicherheitsabfrage:
Captcha
 
Lösung: